Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

GLUT-4 Deficiency and severe peripheral resistance to insulin in the teleost fish tilapia.

Wright JR., O'Hali W., Yang H., Han XX., Bonen A.

Animal Study on Type 2 Diabetes, published in Gen Comp Endocrinol (1998) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Gen Comp Endocrinol (1998)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
9653018
DOI
10.1006/gcen.1998.7081

Abstract (original English)

Teleost fish, in general, are glucose intolerant; this trait has been attributed to piscine islets secreting insulin primary in response to amino acid secretogogues rather than glucose. However, pancreatic islet from the teleost fish tilapia, when transplanted into diabetic nude mice, were glucose responsive even though tilapia were severely glucose intolerant. This suggested a strong peripheral resistance to the glucostatic effects of insulin. Using Western blotting with polyclonal antibodies as well as Northern analysis for mRNA, tilapia tissues were found to be devoid of GLUT-4, the insulin-sensitive glucose transporter responsible for the hypoglycemic effect of insulin in mammals. The absence of GLUT-4 in peripheral tissues may explain why tilapia, and possibly other teleost fish, are severely glucose intolerant. This suggests that tilapia islets have evolved along mammalian lines to be glucose sensitive while tilapia peripheral tissue have diverged widely. Using the same methods, tilapia were found to have a very limited tissue distribution of the insulin-independent glucose transporter, GLUT-1, which is responsible for basal glucose transport in mammalian cells. It is suggested that tilapia provide a naturally occurring GLUT-4 knockout model.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsBlood GlucoseBlotting, NorthernBlotting, WesternBrain ChemistryGlucose Tolerance TestGlucose Transporter Type 1Glucose Transporter Type 4Insulin Resistance

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research